Investors interested in stocks from the Large Cap Pharmaceuticals sector have probably already heard of Novartis (NVS) and Eli Lilly (LLY). But which of these two stocks is more attractive to value ...

PSI Advisors LLC lifted its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.4% during the third quarter, ...

Grassi Investment Management lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...

Eli Lilly & Co’s Alzheimer’s drug won’t be made available for patients using England’s National Health Service, after the ...

Currently, financial markets are experiencing a mix of optimism and caution as investors react to changing economic ...

PFE's non-COVID drugs and potential contributions from new and newly acquired products have started to drive growth.

Biocurious is renowned healthcare and biotech journalist Tim Boreham’s weekly deep dive into the complex, challenging and ...

Eli Lilly has triggered multiple Buy signals, including Timing, SAR, and Fundamental, with a 12-month target of ~$1,150. See ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.